Invest in Irish Healthcare Innovation with EIIS Tax Relief
Back an Enterprise Ireland-backed HPSU building AI-enhanced practice management software. Vård Digital Health intends to offer EIIS qualification, which may allow eligible investors to qualify for up to 50% income tax relief on their 2026 investment, subject to Revenue approval and meeting all qualifying conditions.
Up to 50%
Income Tax Relief (2026)
€1.2M
Seed Round Target
July 31st 2026
Round Closing Date
EIIS Status: Vård Digital Health intends to apply for and offer EIIS qualification for this investment round. Tax relief is subject to Revenue Commissioners approval, the company and investors meeting all qualifying conditions, and individual circumstances. This is not a guarantee of tax relief. Investors should seek independent tax advice.
Why Invest in Vård Digital Health Through EIIS?
Combining significant tax advantages with a high-growth healthcare technology investment opportunity in Ireland's thriving digital health sector.
Maximum EIIS Tax Relief
Qualify for up to 50% income tax relief as a pre-revenue company investment. Reduce your 2026 tax bill while backing Irish innovation.
Enterprise Ireland Backed
We're an Enterprise Ireland-backed High Potential Start-Up (HPSU). Europe's largest seed-stage investor has validated our technology and growth potential.
€25Bn+ Market Opportunity
Targeting rapidly expanding European healthcare software markets with 8.4% CAGR. Long-term care market alone reaching €13.4Bn by 2033.
AI-Enhanced Technology
KarePilot leverages artificial intelligence to automate clinical workflows, reduce admin burden, and improve patient outcomes with cutting-edge healthcare software.
Proven Leadership Team
Led by Andy O'Donoghue and Patrick Egan, seasoned health tech entrepreneurs with proven track records in scaling and exiting medical software companies.
Limited Time Opportunity
EIIS component closes July 31st 2026 to qualify for 2026 tax relief. Limited time opportunity to invest.
How EIIS Works for Irish Investors
Employment and Investment Incentive Scheme (EIIS)
The Employment and Investment Incentive Scheme (EIIS) is an Irish government initiative designed to encourage investment in small and medium-sized enterprises (SMEs) by offering income tax relief to eligible investors.
Subject to Revenue approval and personal circumstances, Irish tax residents may obtain up to 50% income tax relief on qualifying investments in pre-revenue companies like Vård Digital Health. The relief is normally available in the year the investment is made, provided EIIS conditions are met. Vård Digital Health intends to apply for EIIS qualification for this investment round closing July 31st 2026.
Based on 50% potential tax relief for pre-revenue companies
Investment Amount
€50,000
Potential Tax Relief (50%)
€25,000
Income Deduction (125%)
€62,500
Effective Net Cost
€25,000
Important: Tax relief calculations are illustrative. Actual relief depends on your individual tax position, total income, and compliance with all EIIS conditions. Consult your tax advisor for personalised guidance.
Your EIIS Investment Journey with Vård
From initial inquiry to receiving your Statement of Qualification for tax relief, we guide you through every step of the EIIS investment process, subject to Revenue approval.
Massive Market Opportunity in Healthcare Technology
Vård Digital Health is positioned in rapidly expanding global healthcare software markets with strong growth trajectories and significant upside potential for EIIS investors.
€15B
Market Size (2023)
~10% CAGR
Projected Growth Rate
Fragmented landscape, ripe for SaaS adoption across clinic and practice management systems.
$9.4B
Projected Market Size by 2028
~10.9% CAGR
Growth Rate
Demographic tailwinds: ageing populations drive digital health demand. Shift to SaaS providers moving away from legacy systems.
$106.8B
Healthcare IT Software (2024)
$5.5B → $13.7B
Practice Management (2024 → 2033)
Patient empowerment: $7.4B (2025 → $25.2B by 2034). Sequenced later: high cost, HIPAA compliance, intense competition.
250,000+
Private Healthcare Providers
Ireland, UK, Australia, New Zealand, Middle East: Lower cost of entry, faster adoption cycles.
Growth Drivers: Ageing populations, shift to SaaS, consumerisation driving mobile-first, seamless experiences.
Short-Term Addressable Market
€25+ Billion
Vård Digital Health's immediate market opportunity across practice management, billing, patient engagement, and long-term care software segments in English-speaking regions with faster adoption cycles.
Experienced Leadership Team
Our founders bring decades of healthcare technology experience, proven track records in scaling companies, and deep expertise in the Irish health tech ecosystem.
Andy O'Donoghue
CEO & Co-Founder
As CEO of KM Medical, Andy grew iMedDoc EBITDA, launched new products in new markets, and successfully sold KM to Clanwilliam Health in 2020. His journey began with a decade writing software at Apple, before moving to healthtech where as CTO & CEO he has scaled companies from start-up to successful acquisition in Ireland and North America.
Patrick Egan
COO & Co-Founder
Patrick brings over a decade of digital transformation experience in healthcare, growing commercial and operations teams across multiple markets. With a proven track record of driving innovation and commercial growth, Patrick has demonstrated expertise in leading companies through significant periods of change and expansion in the health tech sector.
Backed by Leading Irish Investors
Enterprise Ireland
As the Government of Ireland's venture capital and innovation agency, Enterprise Ireland supports over 4,000 Irish companies. As Europe's largest seed-stage investor, their HPSU backing reflects strong institutional confidence in our technology and global growth plans.
Sheridan Jones
Former Director of Business and Strategy at Microsoft with over 20 years' leadership in product strategy and marketing. Successfully launched and scaled multimillion-dollar products globally. Brings both corporate insight and entrepreneurial experience as an investor & board member.
Join us in transforming Irish healthcare
Frequently Asked Questions
Common questions about investing in Vård Digital Health through the EIIS scheme
The Employment and Investment Incentive Scheme (EIIS) is an Irish government initiative designed to encourage investment in small and medium-sized enterprises (SMEs) by offering income tax relief to eligible investors. Subject to Revenue approval and personal circumstances, investors may obtain up to 50% income tax relief on qualifying investments in pre-revenue companies like Vård Digital Health.
For investments in pre-revenue companies like Vård Digital Health made in 2026, Irish tax residents may qualify for up to 50% income tax relief. For example, a €50,000 investment could result in €25,000 in potential tax relief, subject to meeting all EIIS conditions and individual tax circumstances.
EIIS investments must be held for a minimum of 4 years to qualify for and retain the tax relief. Selling shares before the 4-year period may result in clawback of the relief.
The EIIS component of Vård Digital Health's seed round closes in July 31st 2026 to qualify for 2026 tax relief. Don't miss this opportunity to reduce your 2026 tax bill while backing Irish healthcare innovation.
Yes, Vård Digital Health is an Enterprise Ireland-backed High Potential Start-Up (HPSU). Enterprise Ireland is Europe's largest seed-stage investor and their backing reflects strong institutional confidence in our technology and growth plans.
Vård Digital Health operates in rapidly expanding healthcare technology sectors. The European clinic & practice software market is valued at €4.06 billion (2024) growing at 8.4% CAGR to 2031, while the global long-term care software market is projected to grow from €5.7 billion (2024) to €13.4 billion by 2033. Our short-term addressable market exceeds €25 billion.
Vård Digital Health is co-founded by Andy O'Donoghue (CEO), who successfully scaled and sold KM Medical to Clanwilliam Health in 2020, and Patrick Egan (COO), who brings over a decade of digital transformation experience in healthcare. Both founders have proven track records in the Irish health tech ecosystem.
After submitting your inquiry, we'll send you our comprehensive investment pack including pitch deck, detailed financials, and term sheet. We'll then arrange a call with founders Andy O'Donoghue and Patrick Egan to discuss the opportunity, answer your questions, and guide you through the EIIS investment process.
Ready to Invest in Irish Healthcare Innovation?
Join our EIIS 2026 seed round before July 31st 2026 and qualify for up to 50% income tax relief while backing the future of healthcare technology in Ireland.
Questions? Contact us at hello@vardhealth.com or call +353 1 223 2933